InsidersTradesSigma
Track the Wuhan YZY Biopharma Co., Ltd. - B stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Wuhan YZY Biopharma Co., Ltd. - B has logged 8 reports. Market capitalisation: €740.7m. The latest transaction was reported on 1 April 2026 (Purchase). Among the most active insiders: WEN Zhicheng. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
4 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2026
Declarations8 total
5,059,039 sharesShareXHKGHKEX:DA20260331E00384
5,059,039 sharesShareXHKGHKEX:DA20260331E00383
54,262,305 sharesShareXHKGHKEX:DA20260331E00393
54,262,305 sharesShareXHKGHKEX:DA20260331E00392
54,262,305 sharesShareXHKGHKEX:DA20260331E00391
54,262,305 sharesShareXHKGHKEX:DA20260331E00390
8 of 8 declarations
关于 Wuhan YZY Biopharma Co., Ltd. - B
武汉友芝友生物制药有限公司是一家专注于健康和制药领域的公司。它在香港证券交易所（XHKG）上市。